Literature DB >> 33491828

Unraveling antimicrobial resistance in Helicobacter pylori: Global resistome meets global phylogeny.

Tal Domanovich-Asor1, Hillary A Craddock1, Yair Motro1, Boris Khalfin1, Avi Peretz2, Jacob Moran-Gilad1.   

Abstract

BACKGROUND: Antimicrobial resistance (AMR) in Helicobacter pylori is increasing globally and can result in treatment failure and inappropriate antibiotic usage. This study used whole genome sequencing (WGS) to conduct an analysis of the H. pylori resistome and phylogeny. MATERIALS/
METHODS: A total of 1040 H. pylori isolate sequences were retrieved. Analysis was conducted via an in-house bioinformatics pipeline targeting point mutations in selected genes frequently associated with AMR (pbp1A, 23S rRNA, gyrA, rdxA, frxA, and rpoB) and phylogenomic analyses using core genome multilocus sequence typing (cgMLST).
RESULTS: Phylogenomic analysis revealed a notable geographical clustering of H. pylori genomes across world regions, but large distances of more than 1000 loci between isolates on individual branches were observed. Resistome analysis revealed the prevalence of common mutations which have previously been found to correlate with phenotypic antibiotic resistance; the most common point mutations for each gene were S589G (pbp1A, 48.8% of perfect aligned sequences), A2143G (23S rRNA, 27.4% of perfectly aligned sequences), N87 K\I\Y (gyrA, 14.7% of perfectly aligned sequences), R131K (rdxA, 65.7% of perfectly aligned sequences), and C193S (frxA, 62.6% of perfectly aligned sequences).
CONCLUSIONS: This is the largest study to date featuring the global phylogeny of H. pylori in conjunction with a global snapshot of the H. pylori resistome based on >1000 genomes. Further analyses that combine WGS and phenotypic methods will provide further understanding of the association between the mutations and resistance.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Helicobacter pylorizzm321990; Antimicrobial resistance; Whole Genome Sequencing; cgMLST; global epidemiology

Year:  2021        PMID: 33491828     DOI: 10.1111/hel.12782

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  3 in total

Review 1.  Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data.

Authors:  Joana S Vital; Luís Tanoeiro; Ricardo Lopes-Oliveira; Filipa F Vale
Journal:  Biomolecules       Date:  2022-05-11

2.  Characteristics of Helicobacter pylori Heteroresistance in Gastric Biopsies and Its Clinical Relevance.

Authors:  You-Hua Wang; Xiao-Ling Gong; Ding-Wei Liu; Rong Zeng; Lin-Fu Zhou; Xiao-Yan Sun; Dong-Sheng Liu; Yong Xie
Journal:  Front Cell Infect Microbiol       Date:  2022-02-04       Impact factor: 5.293

3.  Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.

Authors:  Kazumi Inokuchi; Hideki Mori; Juntaro Matsuzaki; Kenro Hirata; Yosuke Harada; Yoshimasa Saito; Hidekazu Suzuki; Takanori Kanai; Tatsuhiro Masaoka
Journal:  Helicobacter       Date:  2022-05-29       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.